DK1987052T3 - Syntese af glucagonlignende peptider - Google Patents

Syntese af glucagonlignende peptider

Info

Publication number
DK1987052T3
DK1987052T3 DK07702683.9T DK07702683T DK1987052T3 DK 1987052 T3 DK1987052 T3 DK 1987052T3 DK 07702683 T DK07702683 T DK 07702683T DK 1987052 T3 DK1987052 T3 DK 1987052T3
Authority
DK
Denmark
Prior art keywords
glucagon
peptides
synthesis
devised
peptide
Prior art date
Application number
DK07702683.9T
Other languages
English (en)
Inventor
Carsten Meininghaus
Oleg Werbitzky
Stephane Varray
Matthieu Giraud
Original Assignee
Lonza Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Ag filed Critical Lonza Ag
Application granted granted Critical
Publication of DK1987052T3 publication Critical patent/DK1987052T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/605Glucagons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/10General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using coupling agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK07702683.9T 2006-02-08 2007-01-11 Syntese af glucagonlignende peptider DK1987052T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06002537 2006-02-08
PCT/EP2007/000198 WO2007090496A1 (en) 2006-02-08 2007-01-11 Synthesis of glucagon-like peptide

Publications (1)

Publication Number Publication Date
DK1987052T3 true DK1987052T3 (da) 2011-08-15

Family

ID=37697824

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07702683.9T DK1987052T3 (da) 2006-02-08 2007-01-11 Syntese af glucagonlignende peptider

Country Status (19)

Country Link
US (2) US8445433B2 (da)
EP (1) EP1987052B1 (da)
JP (1) JP5199126B2 (da)
KR (1) KR101297942B1 (da)
CN (1) CN101379075B (da)
AT (1) ATE507235T1 (da)
AU (1) AU2007214088B2 (da)
BR (1) BRPI0707599A2 (da)
CA (1) CA2641053A1 (da)
DE (1) DE602007014184D1 (da)
DK (1) DK1987052T3 (da)
ES (1) ES2364982T3 (da)
IL (1) IL193134A (da)
MX (1) MX2008010136A (da)
NO (1) NO20083378L (da)
PT (1) PT1987052E (da)
TW (1) TWI404724B (da)
WO (1) WO2007090496A1 (da)
ZA (1) ZA200806690B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5473925B2 (ja) 2007-10-27 2014-04-16 コーデン ファーマ コロラド インコーポレイテッド 固相および溶液相の組み合わせ技法を使用するインスリン分泌性ペプチドの合成
CN101903400B (zh) * 2007-12-11 2013-12-18 霍夫曼-拉罗奇有限公司 使用固相和液相组合技术的促胰岛素肽合成
WO2010125079A2 (en) * 2009-05-01 2010-11-04 F. Hoffmann-La Roche Ag Insulinotropic peptide synthesis using solid and solution phase combination techniques
CN102250235A (zh) * 2011-06-23 2011-11-23 成都圣诺科技发展有限公司 奈西立肽的制备方法
GB201310921D0 (en) 2013-06-19 2013-07-31 Chemical & Biopharmaceutical Lab Of Patras S A Peptide-resin conjugate and use thereof
EP3080153A2 (en) * 2013-12-13 2016-10-19 Medimmune Limited Protease resistant peptides
CN104017064B (zh) * 2014-06-13 2016-08-24 杭州阿诺生物医药科技股份有限公司 一种制备特立帕肽的方法
GR20140100479A (el) 2014-09-23 2016-05-05 Novetide, Ltd., Συνθεση λιραγλουτιδης
CN104356221B (zh) * 2014-10-24 2018-06-26 杭州阿诺生物医药科技股份有限公司 一种制备培西加南的方法
US11117946B2 (en) 2016-03-23 2021-09-14 Bachem Holding Ag Method for preparing glucagon-like peptides
EP3692056A1 (en) 2017-10-04 2020-08-12 Chemical & Biopharmaceutical Laboratories of Patras S.A. A process for preparing a glucagon-like peptide
WO2020127476A1 (en) 2018-12-19 2020-06-25 Krka, D.D., Novo Mesto Pharmaceutical composition comprising glp-1 analogue
WO2020190757A1 (en) 2019-03-15 2020-09-24 Novetide Ltd. Improved processes for the preparation of semaglutide
WO2021123228A1 (en) 2019-12-18 2021-06-24 Krka, D.D., Novo Mesto Pharmaceutical composition comprising glp-1 analogue
CN116925237A (zh) 2019-12-31 2023-10-24 北京质肽生物医药科技有限公司 Glp-1和gdf15的融合蛋白以及其缀合物
EP4222176A4 (en) 2020-09-30 2024-02-28 Beijing Ql Biopharmaceutical Co Ltd POLYPEPTIDE CONJUGATES AND METHODS OF USE
CN114249808A (zh) * 2021-12-27 2022-03-29 杭州诺泰澳赛诺医药技术开发有限公司 一种Cagrilintide的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421303A1 (de) * 1984-06-08 1985-12-12 Hoechst Ag, 6230 Frankfurt Salze aus 3-hydroxy-4-oxo-3,4-dihydro-1,2,3-benzotriazin und amino-verbindungen
US5574008A (en) * 1994-08-30 1996-11-12 Eli Lilly And Company Biologically active fragments of glucagon-like insulinotropic peptide
US6268343B1 (en) * 1996-08-30 2001-07-31 Novo Nordisk A/S Derivatives of GLP-1 analogs
US6329336B1 (en) * 1999-05-17 2001-12-11 Conjuchem, Inc. Long lasting insulinotropic peptides
EP1257577B1 (en) * 2000-01-27 2004-04-21 Eli Lilly And Company Process for solubilizing glucagon-like peptide 1 (glp-1) compounds
US6969702B2 (en) 2002-11-20 2005-11-29 Neuronova Ab Compounds and methods for increasing neurogenesis
KR101241862B1 (ko) * 2003-09-19 2013-03-13 노보 노르디스크 에이/에스 신규 glp-1 유도체
WO2006097538A1 (en) * 2005-03-18 2006-09-21 Novo Nordisk A/S Extended glp-1 compounds

Also Published As

Publication number Publication date
IL193134A0 (en) 2009-02-11
WO2007090496A1 (en) 2007-08-16
US8445433B2 (en) 2013-05-21
KR20080100448A (ko) 2008-11-18
JP5199126B2 (ja) 2013-05-15
US20090292106A1 (en) 2009-11-26
ZA200806690B (en) 2009-07-29
PT1987052E (pt) 2011-07-25
ES2364982T3 (es) 2011-09-20
BRPI0707599A2 (pt) 2011-05-10
MX2008010136A (es) 2008-12-19
IL193134A (en) 2014-06-30
CA2641053A1 (en) 2007-08-16
DE602007014184D1 (de) 2011-06-09
TW200745157A (en) 2007-12-16
ATE507235T1 (de) 2011-05-15
CN101379075B (zh) 2013-05-15
CN101379075A (zh) 2009-03-04
EP1987052A1 (en) 2008-11-05
US9040480B2 (en) 2015-05-26
US20130324699A1 (en) 2013-12-05
NO20083378L (no) 2008-10-31
TWI404724B (zh) 2013-08-11
EP1987052B1 (en) 2011-04-27
AU2007214088A1 (en) 2007-08-16
KR101297942B1 (ko) 2013-08-19
AU2007214088B2 (en) 2012-03-22
JP2009525997A (ja) 2009-07-16

Similar Documents

Publication Publication Date Title
DK1987052T3 (da) Syntese af glucagonlignende peptider
DK1737889T3 (da) Fremgangsmåde til fastfase-peptidsyntese
DK2035554T3 (da) Celle-fri syntese af proteiner indeholdende ikke-naturlige aminosyrer
DK1951747T3 (da) Fremgangsmåde og mellemprodukter til syntese af caspofungin
DK2207791T4 (da) Krystallinske peptidepoxyketon-proteasehæmmere og syntese af aminosyreketoepoxider
DK1987159T4 (da) Fremgangsmåde til sekventering af en polynukleotidtemplate
MX2009008271A (es) Procesos e intermediarios para la preparacion de un inhibidor de proteasa macrocilico del vhc.
NO20074623L (no) Fremgangsmate for peptidsyntese
DK2035451T3 (da) Insulinoptrop peptidsyntese
EA201101015A1 (ru) Способ получения бивалирудина
NO20084776L (no) En fremgangsmåte for konsentrasjon av et polypeptid
HRP20080554A2 (en) Process for preparation of hiv protease inhibitors
EA200801884A1 (ru) Новый способ синтеза ранелата стронция и его гидратов
DK2019118T3 (da) Fremgangsmåde til syntetisering af thymosiner
TW200728310A (en) Process for the preparation of ferri-succinylcasein
SV2011003923A (es) 3-aminociclopentancarboxamidas
CY1121966T1 (el) Παραγωγα πεπτιδιου οπιορφινης ως ισχυροι αναστολεις εκτοπεπτιδασων αποδομησεως εγκεφαλινης
DK1700823T3 (da) Fremgangsmåde til fremstilling af syntesegas
DK1869066T3 (da) Peptidsyntese af alfa-spiraler på PEG-harpiks
UA94604C2 (en) Neuroprotective compounds and uses thereof
NO20042003L (no) Fremgangsmate for 2-trinns syntese av heksanitroheksaazaisowurtzitan ved a starte fra et primaert amin
DK1542968T3 (da) Fremgangsmåde til fremstilling af mellemforbindelser
DK1805203T3 (da) Peptid-cyklisering på harpiks
DK1856125T3 (da) Syntese af proteasehæmmerforstadie
IL199752A0 (en) Purification of taci-fc